Roxarsone withdrawn from Canadian market

Pfizer Animal Health Canada and Winnipeg veterinary drug distributors Dominion Veterinary Laboratories are to suspend sales of Roxarsone as sold in the products 3-Nitro-20 and Super Nitro-12, effective August 8. The American subsidiary of Pfizer's in the US are planning to take the same action where Roxarsone is concerned in response to request from the US food and drug administration (FDA).

According to a notice from Health Canada's Veterinary Drugs Directorate, the FDA study had found inorganic arsenic, a known carcinogen, at higher levels in the livers of chickens treated with the Nitro drugs, compared with untreated chickens. Health Canada said it had reviewed the FDA study and agrees with its conclusion that the levels of inorganic arsenic involved were "very low" and posed no immediate health risk to people eating meat from birds treated with the drugs. Read more ...

This blog is written by Martin Little, The Global Miller, published and supported by the GFMT Magazine and the International Milling Directory from Perendale Publishers